GABBR2 as a Downstream Effector of the Androgen Receptor Induces Cisplatin Resistance in Bladder Cancer

The precise molecular mechanisms responsible for resistance to cisplatin-based chemotherapy in patients with bladder cancer remain elusive, while we have indicated that androgen receptor (AR) activity in urothelial cancer is associated with its sensitivity. Our DNA microarray analysis in control vs....

Descripción completa

Detalles Bibliográficos
Autores principales: Elahi Najafi, Mohammad Amin, Yasui, Masato, Teramoto, Yuki, Tatenuma, Tomoyuki, Jiang, Guiyang, Miyamoto, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530579/
https://www.ncbi.nlm.nih.gov/pubmed/37762034
http://dx.doi.org/10.3390/ijms241813733

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10530579/
https://www.ncbi.nlm.nih.gov/pubmed/37762034
http://dx.doi.org/10.3390/ijms241813733

Ejemplares similares